Hypoglycemic Agents
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes (NCT04809220) | Eli Lilly and Company | 2021-04-13 |
| Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 (NCT04371978) | Rabin Medical Center | 2020-10-01 |
| Analysis of Ergogenic Potential and Risks Associated With Acute and Chronic Use of Sulphonylureas on Physical Exercise (NCT04443777) | Instituto de Cardiologia do Rio Grande do Sul | 2020-06-01 |
| Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production (NCT03852901) | National Institute on Aging (NIA) | 2019-03-28 |
| Antidiabetic Drugs for Steatotic Liver Disease (NCT03646292) | Yonsei University | 2018-12-06 |
| The Effects of Empagliflozin on Arterial Wall Characteristics (NCT03639545) | University Medical Centre Ljubljana | 2018-03-01 |
| Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes (NCT01867502) | Hospital de Clinicas de Porto Alegre | 2014-04-01 |
Track Hypoglycemic Agents automatically
Every clearance here is in the API, with alerts when new ones post.